Skip to Content

Abu Dhabi’s sovereign investor Mubadala Investment Company PJSC (Mubadala) has reached a definitive agreement to purchase KELIX bio, a specialty pharmaceutical company that focuses on providing complex generic drugs in emerging markets. This acquisition aims to strengthen the development of the life sciences ecosystem in the UAE, establish the UAE as a global leader in […]

Read More about Abu Dhabi’s Mubadala expands life sciences portfolio with acquisition of Kelix Bio